down arrow

CVS Health Corp.

  • Market Cap: Large Cap
  • Industry: Retailing
  • ISIN: US1266501006
USD
76.75
1.75 (2.33%)

Dec 04

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

74.1476.78

52 Week

43.5685.15
Valuation
Technical
Day's Volume

CASH

8.87 M

Shareholding (Mar 2025)

FII

16.70%

Held by 546 FIIs

DII

40.75%

Held by 162 DIIs

Promoter

0.07%

How big is CVS Health Corp.?

22-Jun-2025

As of Jun 18, CVS Health Corp. has a market capitalization of $113.18 billion. For the latest 4 quarters, net sales totaled $378.85 billion, with a net profit of $5.24 billion.

As of Jun 18, CVS Health Corp. has a market capitalization of 113,182.13 million, categorizing it as a Large Cap company.<BR><BR>As of Jun 24, the sum of Net Sales for the latest 4 quarters is 378,846.00 million, while the sum of Net Profit for the same period is 5,244.00 million.<BR><BR>As of Dec 24, the reporting period shows Shareholder's Funds at 75,560.00 million and Total Assets at 260,822.00 million.

Read More

What does CVS Health Corp. do?

22-Jun-2025

CVS Health Corporation is an integrated pharmacy healthcare company with a market cap of approximately $113.18 billion, reporting net sales of $94.61 billion and a net profit of $1.78 billion as of March 2025. Key metrics include a P/E ratio of 17.00 and a dividend yield of 227.13%.

Overview:<BR>CVS Health Corporation is an integrated pharmacy healthcare company operating in the Retailing industry, with a market capitalization in the large-cap bracket.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 94,609 Million (Quarterly Results - Mar 2025)<BR>Most recent Net Profit: 1,782 Million (Quarterly Results - Mar 2025)<BR>Market-cap: USD 113,182.13 Million (Large Cap)<BR><BR>Key Metrics:<BR>P/E: 17.00<BR>Dividend Yield: 227.13%<BR>Debt Equity: 0.70<BR>Return on Equity: 8.14%<BR>Price to Book: 1.47<BR><BR>Contact Details:<BR>Address: 1 Cvs Dr, WOONSOCKET RI: 02895-6146<BR>Tel: 1 401 7651500<BR>Website: https://cvshealth.com/

Read More

Who are in the management team of CVS Health Corp.?

22-Jun-2025

As of March 2022, the management team of CVS Health Corp. includes Independent Chairman David Dorman, President and CEO Larry Merlo, and several Independent Directors: Fernando Aguirre, C. David Brown, Alecia DeCoudreaux, Nancy-Ann DeParle, and Roger Farah. They oversee the company's strategic direction and operations.

As of March 2022, the management team of CVS Health Corp. includes the following individuals:<BR><BR>- Mr. David Dorman, who serves as the Independent Chairman of the Board.<BR>- Mr. Larry Merlo, who is the President, Chief Executive Officer, and a Director.<BR>- Mr. Fernando Aguirre, an Independent Director.<BR>- Mr. C. David Brown, an Independent Director.<BR>- Ms. Alecia DeCoudreaux, an Independent Director.<BR>- Ms. Nancy-Ann DeParle, an Independent Director.<BR>- Mr. Roger Farah, an Independent Director. <BR><BR>This team is responsible for overseeing the strategic direction and operations of the company.

Read More

Is CVS Health Corp. technically bullish or bearish?

20-Sep-2025

As of August 18, 2025, CVS Health Corp. has a bullish technical trend, supported by positive MACD and moving averages, while outperforming the S&P 500 year-to-date with a return of 65.78%.

As of 18 August 2025, the technical trend for CVS Health Corp. has changed from mildly bullish to bullish. The weekly MACD is bullish, and the daily moving averages also indicate a bullish stance. The Bollinger Bands show a bullish signal on the monthly timeframe. However, the RSI does not provide any clear signals on both weekly and monthly timeframes. <BR><BR>In terms of performance, CVS has outperformed the S&P 500 year-to-date with a return of 65.78% compared to the S&P 500's 12.22%. Over the past year, CVS returned 27.39% against the S&P 500's 17.14%. Overall, the current technical stance is bullish, supported by multiple indicators, though some metrics show only mild bullishness.

Read More

Is CVS Health Corp. overvalued or undervalued?

21-Oct-2025

As of October 17, 2025, CVS Health Corp. is considered overvalued with a P/E ratio of 17 compared to the industry average of 19.83, despite a strong year-to-date stock performance of 83.83%, but it has a three-year return of -9.21%, indicating potential volatility and risk.

As of 17 October 2025, CVS Health Corp. has moved from very expensive to expensive, indicating a slight improvement in its valuation stance but still suggesting it is overvalued. The company is currently assessed as overvalued based on its P/E ratio of 17, which is below its peer average of approximately 19.83, and an EV to EBITDA ratio of 9.97, which also indicates a premium compared to its peers. Additionally, the Price to Book Value stands at 1.39, further supporting the notion of overvaluation.<BR><BR>In comparison to its peers, CVS Health Corp. exhibits a lower P/E ratio than the industry average, while its EV to EBITDA is slightly more favorable than some competitors, suggesting it may not be as attractive as it appears. Notably, the company's recent stock performance has outpaced the S&P 500, with a year-to-date return of 83.83% compared to the S&P 500's 13.30%, but this strong performance is overshadowed by a three-year return of -9.21% versus the S&P 500's 81.19%, highlighting potential volatility and risk.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Healthy long term growth as Net Sales has grown by an annual rate of 7.94%

 
2

Flat results in Jun 25

3

With ROCE of 8.83%, it has a very expensive valuation with a 1.23 Enterprise value to Capital Employed

4

Market Beating Performance

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Retailing

stock-summary
Market cap

USD 118,762 Million (Large Cap)

stock-summary
P/E

17.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

145.25%

stock-summary
Debt Equity

0.70

stock-summary
Return on Equity

7.74%

stock-summary
Price to Book

1.53

Revenue and Profits:
Net Sales:
98,942 Million
(Quarterly Results - Jun 2025)
Net Profit:
1,013 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
4.15%
0%
4.15%
6 Months
20.73%
0%
20.73%
1 Year
32.21%
0%
32.21%
2 Years
12.08%
0%
12.08%
3 Years
-25.18%
0%
-25.18%
4 Years
-15.54%
0%
-15.54%
5 Years
3.02%
0%
3.02%

CVS Health Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
CVS Health Corp. Hits Day Low of $75.92 Amid Price Pressure

CVS Health Corp. Hits Day Low of $75.92 Amid Price Pressure

CVS Health Corp. saw a significant stock decline today, contrasting with the stable S&P 500. Despite a recent downturn, CVS has outperformed the index annually and maintains a strong market position with a high institutional ownership rate and consistent long-term sales growth.

Read More
CVS Health Faces Weak Start with Significant Gap Down Amid Market Concerns

CVS Health Faces Weak Start with Significant Gap Down Amid Market Concerns

CVS Health Corp. opened with a significant stock price decline, contrasting with the S&P 500's stability. The company has a market capitalization of approximately USD 118.76 billion, a P/E ratio of 17.00, and a notable dividend yield. Financial metrics indicate mixed technical indicators as CVS adapts to market conditions.

Read More
CVS Health Corp. Hits New 52-Week High of $85.15

CVS Health Corp. Hits New 52-Week High of $85.15

CVS Health Corp. achieved a new 52-week high of USD 85.15 on October 29, 2025, reflecting strong performance in the retail sector. The company has a market capitalization of USD 118.76 billion, a P/E ratio of 17.00, and a notable dividend yield, indicating solid financial health.

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
7.94%
EBIT Growth (5y)
-4.24%
EBIT to Interest (avg)
5.45
Debt to EBITDA (avg)
2.69
Net Debt to Equity (avg)
0.70
Sales to Capital Employed (avg)
2.57
Tax Ratio
27.01%
Dividend Payout Ratio
72.76%
Pledged Shares
0
Institutional Holding
90.92%
ROCE (avg)
11.63%
ROE (avg)
12.35%
Valuation key factors
Factor
Value
P/E Ratio
17
Industry P/E
Price to Book Value
1.39
EV to EBIT
13.96
EV to EBITDA
9.97
EV to Capital Employed
1.23
EV to Sales
0.43
PEG Ratio
NA
Dividend Yield
239.67%
ROCE (Latest)
8.83%
ROE (Latest)
8.14%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 243 Schemes (42.47%)

Foreign Institutions

Held by 546 Foreign Institutions (16.7%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 8.34% vs 2.59% in Jun 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -42.70% vs -7.63% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "98,942.00",
          "val2": "91,324.00",
          "chgp": "8.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4,485.00",
          "val2": "4,388.00",
          "chgp": "2.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "768.00",
          "val2": "727.00",
          "chgp": "5.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-906.00",
          "val2": "-102.00",
          "chgp": "-788.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,013.00",
          "val2": "1,768.00",
          "chgp": "-42.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "33.50%",
          "val2": "35.40%",
          "chgp": "-0.19%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 4.02% vs 10.99% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -45.20% vs 93.39% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "372,692.00",
          "val2": "358,273.00",
          "chgp": "4.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "14,518.00",
          "val2": "19,949.00",
          "chgp": "-27.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2,938.00",
          "val2": "2,639.00",
          "chgp": "11.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1,031.00",
          "val2": "-994.00",
          "chgp": "-3.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4,586.00",
          "val2": "8,368.00",
          "chgp": "-45.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.60%",
          "val2": "43.50%",
          "chgp": "-1.69%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
98,942.00
91,324.00
8.34%
Operating Profit (PBDIT) excl Other Income
4,485.00
4,388.00
2.21%
Interest
768.00
727.00
5.64%
Exceptional Items
-906.00
-102.00
-788.24%
Consolidate Net Profit
1,013.00
1,768.00
-42.70%
Operating Profit Margin (Excl OI)
33.50%
35.40%
-0.19%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is 8.34% vs 2.59% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -42.70% vs -7.63% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
372,692.00
358,273.00
4.02%
Operating Profit (PBDIT) excl Other Income
14,518.00
19,949.00
-27.22%
Interest
2,938.00
2,639.00
11.33%
Exceptional Items
-1,031.00
-994.00
-3.72%
Consolidate Net Profit
4,586.00
8,368.00
-45.20%
Operating Profit Margin (Excl OI)
26.60%
43.50%
-1.69%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 4.02% vs 10.99% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -45.20% vs 93.39% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About CVS Health Corp. stock-summary
stock-summary
CVS Health Corp.
Retailing
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc. (Omnicare) and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. It operates through three segments: Pharmacy Services, Retail/LTC and Corporate. The Pharmacy Services Segment provides a range of pharmacy benefit management (PBM) solutions to its clients. As of December 31, 2016, the Retail/LTC Segment included 9,709 retail locations (of which 7,980 were its stores that operated a pharmacy and 1,674 were its pharmacies located within Target Corporation (Target) stores), its online retail pharmacy Websites, CVS.com, Navarro.com and Onofre.com.br, 38 onsite pharmacy stores, its long-term care pharmacy operations and its retail healthcare clinics.
Company Coordinates stock-summary
Company Details
1 Cvs Dr , WOONSOCKET RI : 02895-6146
stock-summary
Tel: 1 401 7651500
stock-summary
https://cvshealth.com/
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."